Precipio Diagnostics and Transgenomic Complete Merger

Company Renamed Precipio, Inc.–To Commence Trading On NASDAQ Under The New Ticker “PRPO” NEW HAVEN, Conn. and OMAHA, Neb., (June 30, 2017) – Precipio Diagnostics, LLC and Transgenomic Inc. (OTCQB: TBIOD) today announced the closing of their previously announced merger. In connection with the transaction, Transgenomic has changed its name to Precipio, Inc. Precipio’s common stock... Read more

New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections

New antimicrobial options, including ceftolozane/tazobactam and ceftazidime/avibactam, and extended dilution ranges enable targeted treatment recommendations (PRNewsfoto/Thermo Fisher Scientific Inc.) EAST GRINSTEAD, England, June 29, 2017 /PRNewswire/ — A new FDA-cleared microbroth dilution plate for antimicrobial susceptibility (AST) of Gram negative organisms is now available in the U.S., including two of the latest novel compounds, ceftolozane/tazobactam and ceftazidime/avibactam. The... Read more

Thermo Fisher Scientific Adds Three New Products to Leading Semiconductor Portfolio

New products designed to help semiconductor failure analysis labs achieve higher volumes of samples and faster time-to-data HILLSBORO, Ore., June 29, 2017 /PRNewswire/ — For semiconductor manufacturers seeking fast, high-quality electrical and physical failure analysis, Thermo Fisher Scientific today announced three new additions to its broad portfolio of semiconductor failure analysis workflows. The company will demonstrate these products and... Read more

ENZO BIOCHEM REPORTS DELAWARE COURT RULING

NEW YORK, NY, June 29, 2017 – Enzo Biochem Inc. (NYSE: ENZ) reported today that a federal judge for the U.S. District Court for the District of Delaware has entered an order in the actions entitled Enzo Life Sciences, Inc. v. Gen-Probe Incorporated, Enzo Life Sciences, Inc. v. Hologic, Inc., Enzo Life Sciences, Inc. v. Roche Molecular... Read more

The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains CFDA Approval as Medical Device for in vitro Diagnostic Use

The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market access requirements for medical device products. 1 June 29, 2017 Shanghai, China — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that... Read more

Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Developed to support assay development and validation for detection of anti-drug antibodies   Uppsala, Sweden, June 29th, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.  ... Read more

New Prep-4388 Preparative SFC System

By John Burchell / June 29, 2017 Prep-4388 Preparative SFC System The all new Prep-4388 preparative SFC system includes many new features, such as mass directed prep using a single quad MS detector, a higher flow rate pump with increased pressure limit for 3cm columns and increased productivity. Automated CO2 shutoff valves for easy priming and to prevent backflow... Read more

Smiths Detection’s IONSCAN 600 Explosives Trace Detection System Receives Certification

29 Jun 2017  Print this page Edgewood, Md. – Smiths Detection’s IONSCAN 600 has passed certification testing for the explosives trace detection system by Transportation Security Administration (TSA).  Certification testing is the first of three phases in TSA’s overall qualification process and is necessary in order to be placed on TSA’s Qualified Products List (QPL) for explosives... Read more